Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAbbvie Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 13 | $2.96 | $3.16 | $3.00 |
| Q2 2026 | 13 | $3.49 | $3.98 | $3.76 |
| Q3 2026 | 5 | $3.78 | $3.91 | $3.84 |
| Q4 2026 | 5 | $3.90 | $4.03 | $3.96 |
| Q1 2027 | 5 | $3.20 | $3.31 | $3.25 |
| Q2 2027 | 5 | $4.04 | $4.19 | $4.11 |
| Q3 2027 | 5 | $4.08 | $4.23 | $4.15 |
| Q4 2027 | 5 | $4.30 | $4.45 | $4.37 |
Abbvie Inc Earnings Date And Information
Abbvie Inc last posted its earnings results on Wednesday, February 4th, 2026. The company reported $2.71 earnings per share for the quarter, topping analysts' consensus estimates of $2.65 by $0.06. The company had revenue of 16.62 B for the quarter and had revenue of 61.16 B for the year. Abbvie Inc has generated $2 earnings per share over the last year ($2.36 diluted earnings per share) and currently has a price-to-earnings ratio of 95.6. Abbvie Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Abbvie Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/20/2026 | Q4 2025 | N/A | $1.02 | N/A | $16.41 B | $16.62 B |
| 11/04/2025 | Q3 2025 | N/A | $0.10 | N/A | $15.59 B | $15.78 B |
| 08/04/2025 | Q2 2025 | N/A | $0.53 | N/A | $15.03 B | $15.42 B |
| 05/09/2025 | Q1 2025 | N/A | $0.72 | N/A | $12.93 B | $13.34 B |
| 02/14/2025 | Q4 2024 | N/A | -$0.02 | N/A | $14.83 B | $15.10 B |
| 11/04/2024 | Q3 2024 | N/A | $0.88 | N/A | $14.28 B | $14.46 B |
| 08/07/2024 | Q2 2024 | N/A | $0.77 | N/A | $14.02 B | $14.46 B |
| 05/03/2024 | Q1 2024 | N/A | $0.77 | N/A | $11.93 B | $12.31 B |
| 02/20/2024 | Q4 2023 | N/A | $0.46 | N/A | N/A | $14.30 B |
| 11/06/2023 | Q3 2023 | N/A | $1.00 | N/A | N/A | $13.93 B |
| 08/07/2023 | Q2 2023 | N/A | $1.14 | N/A | N/A | $13.87 B |
| 05/05/2023 | Q1 2023 | N/A | $0.13 | N/A | N/A | $12.23 B |
| 02/17/2023 | Q4 2022 | N/A | $1.40 | N/A | N/A | $15.12 B |
| 11/04/2022 | Q3 2022 | N/A | $2.23 | N/A | N/A | $14.81 B |
| 08/04/2022 | Q2 2022 | N/A | $0.52 | N/A | N/A | $14.58 B |
| 05/06/2022 | Q1 2022 | N/A | $2.54 | N/A | N/A | $13.54 B |
| 02/18/2022 | Q4 2021 | N/A | $2.29 | N/A | N/A | $14.89 B |
| 11/02/2021 | Q3 2021 | N/A | $1.78 | N/A | N/A | $14.34 B |
| 08/02/2021 | Q2 2021 | N/A | $0.42 | N/A | N/A | $13.96 B |
| 05/07/2021 | Q1 2021 | N/A | $2.00 | N/A | N/A | $13.01 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Abbvie Inc Earnings: FAQ's
In the previous quarter, Abbvie Inc (:ABBV) reported $2.71 earnings per share (EPS) to beat the analysts' consensus estimate of $2.65 by $0.06.
The conference call for Abbvie Inc's latest earnings report can be listened to online.
The conference call transcript for Abbvie Inc's latest earnings report can be read online.
Abbvie Inc (:ABBV) has a recorded annual revenue of $61.16 B.
Abbvie Inc (:ABBV) has a recorded net income of $4.23 B.Abbvie Inc has generated $2.38 earnings per share over the last four quarters.
Abbvie Inc (:ABBV) has a price-to-earnings ratio of 95.6 and price/earnings-to-growth ratio is 1.22.